QQQ na na (na)
DIA na na (na)
SPY na na (na)
TLT na na (na)
GLD na na (na)
$ na
-- x --
-- x --
-- - --
na - na
0
na
na
na
na
TBD
na
na (na)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 morgan-stanley-maintains-overweight-on-io-biotech-raises-price-target-to-6

Morgan Stanley analyst Matthew Harrison maintains IO Biotech (NASDAQ:IOBT) with a Overweight and raises the price target fro...

 hc-wainwright--co-reiterates-buy-on-io-biotech-maintains-12-price-target

HC Wainwright & Co. analyst Emily Bodnar reiterates IO Biotech (NASDAQ:IOBT) with a Buy and maintains $12 price target.

 reported-saturday-io-biotech-announced-data-from-phase-2-basket-trial-of-io102-io103-therapeutic-cancer-vaccine-candidate-in-combination-with-mercks-keytruda-at-the-2024-esmo-congress

Study Meets Overall Response Rate Primary Endpoint, Encouraging Secondary Endpoint Progression-Free Survival Data in Squamous C...

 piper-sandler-maintains-overweight-on-io-biotech-maintains-10-price-target

Piper Sandler analyst Christopher Raymond maintains IO Biotech (NASDAQ:IOBT) with a Overweight and maintains $10 price target.

 morgan-stanley-maintains-overweight-on-io-biotech-lowers-price-target-to-4

Morgan Stanley analyst Matthew Harrison maintains IO Biotech (NASDAQ:IOBT) with a Overweight and lowers the price target fro...

 hc-wainwright--co-reiterates-buy-on-io-biotech-maintains-12-price-target

HC Wainwright & Co. analyst Emily Bodnar reiterates IO Biotech (NASDAQ:IOBT) with a Buy and maintains $12 price target.

 hc-wainwright--co-reiterates-buy-on-io-biotech-maintains-12-price-target

HC Wainwright & Co. analyst Emily Bodnar reiterates IO Biotech (NASDAQ:IOBT) with a Buy and maintains $12 price target.

 hc-wainwright--co-maintains-buy-on-io-biotech-raises-price-target-to-12

HC Wainwright & Co. analyst Emily Bodnar maintains IO Biotech (NASDAQ:IOBT) with a Buy and raises the price target from ...

 hc-wainwright--co-reiterates-buy-on-io-biotech-maintains-8-price-target

HC Wainwright & Co. analyst Emily Bodnar reiterates IO Biotech (NASDAQ:IOBT) with a Buy and maintains $8 price target.

 io-biotech-q4-eps-040-misses-039-estimate

IO Biotech (NASDAQ:IOBT) reported quarterly losses of $(0.40) per share which missed the analyst consensus estimate of $(0.39) ...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION